Looking to publish in Inflammopharmacology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginInflammopharmacology is a comprehensive resource on all aspects of inflammation and its pharmacological control, emphasizing pain therapy. It compares different inflammatory states and their causes, examines the actions, therapeutic efficacy and safety of drugs used in the treatment of inflammatory conditions, and covers Conditional Pharmacology/Toxicology, Rheumatology, Gastroenterology, Neuro-Inflammation, and Novel Drugs, Natural Products and Nutraceuticals, with particular emphasis on methods of measurement of clinical response effects of new agents and adverse effects from anti-rheumatic drugs, as well as the safety and efficacy of non-prescription and prescription NSAIDs and analgesics.
Looking to publish in Inflammopharmacology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Inflammopharmacology accepts the following article types. Click on an article type to view submission instructions.
Research
Reviews
Brief Report
Correspondence
Recent Publications
A review on MMP-2 modulating agents from natural and synthetic sources and their role in inflammatory bowel disease
Murugasamy Ragunath, Sudarsan Ardra, Akshad Balde, Rasool Abdul Nazeer
Evaluation of the anti-inflammatory potentials of ethanol leaf extract of Vigna unguiculata in Wistar rats
Adekunle Theophilus Adegbuyi, Aziakpono Moses Omoirri, Oyepata Semeon Joseph, John Oludele Olanlokun, Paul Anton Steenkamp
The dual role of capsaicin in inflammatory bowel disease: from TRPV1-mediated protection to neurogenic inflammation
Luyun Zhang
Synergistic approaches to Alzheimer’s disease: exploring the combined efficacy of phytoconstituents and conventional drugs
Abhishek Kumar
The neuroinflammatory-metabolic loop in parkinsonian neurodegeneration
Khansa Zahid
Frequently asked questions
How long does it take to publish?
All manuscripts are reviewed anonymously by at least two independent reviewers. Articles are published online after receipt of the corrected proofs.
Reformat to Inflammopharmacology using Livewrite PremiumIs a cover letter required?
An accompanying letter submitted with the manuscript should state that the paper is original, unpublished, and not under consideration elsewhere. The corresponding author should mention unpublished material included in the manuscript in a cover letter to the editor.
Reformat to Inflammopharmacology using Livewrite PremiumWhat are the publication costs?
Open access APC: £3290.00 GBP / $5290.00 USD / €4090.00 EUR. Subscription publishing is available with no APC.
Reformat to Inflammopharmacology using Livewrite Premium